Patient underwent medtronic interstim placement for treatment of urinary & fecal incontinence.The interstim stage 1 lead placement was completed without complication.On pod #2 (post operative day), the patient (pt) reported irritation & redness at the surgical site.It was thought to be a reaction to bandage and pt was instructed to use paper tape.Patient also reported feeling tongue swelling but no difficulty breathing/swallowing noted.No further s/s (signs or symptoms) of reaction noted.The next stage was completed without complication - interstim stage 2 insertion of peripheral neurostimulator pulse generator & electronic analysis of implanted neurostimulator pulse generator system.Following stage 2 of the procedure, the patient had signs/symptoms concerning for infection at the surgical site (tenderness, sore, redness, & weeping).Cultures were collected.The patient was treated with antibiotics but failed to improve.The site worsened, progressing to dehiscence of the wound, and the interstim device had to be removed.The surgeon noted concerns for infection and inflammatory process.It has been noted the patient has an allergy to nickel.This device is reportedly nickel-free, but the surgical team noted a concern for possible allergic reaction.Manufacturer response for neurostimulator, interstim surescan lead (per site reporter).The company rep has requested the device for it to be evaluated by the company.
|